SoftOx Solutions Feed

2025-12-05 18:11:09 SoftOx Solutions AS: New Share Capital

2025-11-28 14:32:31 SoftOx Solutions AS: Notice of Extraordinary General Assembly 0,06 NOK | +0,33% | 0,29 MNOK

2025-11-28 14:31:20 SoftOx Solutions AS: SoftOx Solutions AS exercises on the financing facility with Long State Investments Limited 0,06 NOK | +0,33% | 0,29 MNOK

2025-11-26 08:00:00 SoftOx Solutions AS: Third Quarter Report 2025 0,06 NOK | -4,06% | 1,08 MNOK

2025-11-14 08:35:24 SoftOx Solutions AS: GMP Drug Substance Successfully Manufactured - Key Milestone for CF and EDF Clinical Programs 0,08 NOK | +11,43% | 6,51 MNOK

2025-10-16 12:26:31 SoftOx Solutions AS: SoftOx submits Phase 1 Clinical Trial Application under the European Defence Fund (EDF) Program 0,07 NOK | +0,27% | 1,87 MNOK

2025-10-13 08:11:08 SoftOx Solutions AS: New Share Capital 0,07 NOK | -1,60% | 0,17 MNOK

2025-10-07 21:17:54 SoftOx Solutions AS: Private Placement resolved 0,07 NOK | -0,53% | 0,30 MNOK

2025-10-03 15:23:58 SoftOx Solutions AS: New Share Capital 0,08 NOK | -4,47% | 0,21 MNOK

2025-10-01 14:35:30 SoftOx Solutions AS: Clinical Trial Application for Dose Escalation / Cystic Fibrosis Phase 2a - Important Milestone Achieved 0,08 NOK | +9,95% | 2,31 MNOK

2025-09-25 17:51:48 SoftOx Solutions AS: Clarification on Placement Commission 0,08 NOK | +1,22% | 0,43 MNOK

2025-09-25 15:08:52 SoftOx Solutions AS: Private Placements resolved 0,08 NOK | -1,44% | 1,22 MNOK

2025-09-23 09:07:40 SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough 0,08 NOK | -0,48% | 9,60 MNOK

2025-09-23 08:00:00 SoftOx Solutions AS: SoftOx builds momentum: CF trial strategy reinforced by HOCl stability breakthrough 0,08 NOK | -0,48% | 9,60 MNOK

2025-09-17 08:00:00 SoftOx Solutions AS: Second Quarter/Half-Year Report 2025 0,08 NOK | -8,53% | 2,22 MNOK

2025-09-11 15:59:35 SoftOx Solutions AS: Softox Solutions AS exercises on the financing facility with Long State Investments Limited 0,10 NOK | +2,46% | 0,53 MNOK

2025-09-08 12:07:27 SoftOx Solutions AS: Presentation Deck and link to today's Investor Update 0,10 NOK | -18,10% | 6,32 MNOK

2025-09-08 08:00:00 SoftOx Solutions AS: Reminder - Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment 0,10 NOK | -18,10% | 6,32 MNOK

2025-09-03 12:39:27 SoftOx Solutions AS: Investor Update in connection with the Refinement of the Clinical Focus into Chronic Lung Disease Treatment 0,11 NOK | +4,57% | 1,84 MNOK

2025-09-02 08:59:28 SoftOx Solutions AS: Refines Clinical Focus and Advances Into Chronic Lung Disease Treatments 0,11 NOK | -0,45% | 3,09 MNOK

2025-08-26 14:35:51 SoftOx Solutions AS: Primary Insider Notification 0,11 NOK | -1,75% | 1,47 MNOK

2025-08-18 10:36:26 SoftOx Solutions AS: New Share Capital 0,15 NOK | +14,94% | 9,99 MNOK

2025-08-14 22:02:22 SoftOx Solutions AS: Private Placement resolved 0,13 NOK | +19,18% | 13,0 MNOK

2025-08-14 16:28:08 SoftOx Solutions AS: Softox Solutions secures committed financing facility 0,11 NOK | +8,96% | 1,86 MNOK

2025-06-27 14:51:03 SoftOx Solutions AS: SoftOx Solutions AS appoints Dr. Tore Duvold as new board member 0,10 NOK | +26,20% | 11,5 MNOK

2025-06-27 11:08:36 SoftOx Solutions AS: Minutes from the General Meeting 0,10 NOK | +26,20% | 11,5 MNOK

2025-06-27 08:00:00 SoftOx Solutions AS: First Quarter Report 2025 0,10 NOK | +26,20% | 11,5 MNOK

2025-06-13 08:02:29 SoftOx Solutions AS: Notice of Annual General Assembly 0,08 NOK | -3,82% | 0,57 MNOK

2025-06-12 15:08:16 SOFTX: Financial calendar 0,08 NOK | +7,99% | 1,24 MNOK

2025-05-30 08:00:00 SoftOx Solutions AS: Board Member Resignations 0,08 NOK | -5,81% | 0,66 MNOK

2025-05-27 08:00:00 SoftOx Solutions AS: Annual Report 2024 0,09 NOK | -4,22% | 4,12 MNOK

2025-05-23 14:07:34 SOFTX: Financial calendar 0,07 NOK | -9,64% | 2,39 MNOK

2025-04-09 15:30:32 SoftOx Solutions AS: New Share Capital 0,05 NOK | -8,67% | 3,27 MNOK

2025-03-26 08:00:00 SoftOx Solutions AS: Fourth Quarter Report 2024 0,04 NOK | -20,68% | 3,38 MNOK

2025-03-25 10:16:23 SoftOx Solutions AS: Private Placement resolved 0,05 NOK | -2,87% | 3,21 MNOK

2025-03-24 09:23:13 SoftOx Solutions AS: Contemplated Private Placement 0,05 NOK | -34,93% | 23,4 MNOK

2025-02-27 22:52:42 SoftOx Solutions AS: Settlement of legal dispute 0,03 NOK | -1,27% | 0,09 MNOK

2025-02-26 12:33:18 SoftOx Solutions AS: Settlement of legal dispute 0,03 NOK | -4,57% | 0,62 MNOK

2025-02-25 12:36:59 SOFTX: Financial calendar 0,04 NOK | -3,85% | 0,11 MNOK

2025-02-06 12:06:38 SoftOx Solutions AS: In-kind Dividend - SoftOx Wound & Skin Care AS 0,04 NOK | +18,18% | 0,51 MNOK

2025-01-16 10:52:43 SOFTX: Financial calendar 0,01 NOK | -10,67% | 0,01 MNOK

2024-12-27 08:00:00 SoftOx Solutions AS: Ex dividend in-kind today 0,02 NOK | +24,22% | 0,10 MNOK

2024-12-20 10:48:14 SoftOx Solutions AS: Minutes from the ExtraOrdinary General Meeting 0,01 NOK | +11,25% | 0,17 MNOK

2024-12-18 12:13:21 SOFTX: Financial calendar 0,01 NOK | +30,30% | 0,03 MNOK

2024-12-09 09:00:48 SoftOx Solution AS: Mandatory notification of trade by primary insiders and close associates 0,01 NOK | -3,95% | 0,27 MNOK

2024-12-06 12:27:29 SoftOx Solutions AS: Key information relating to in-kind dividend to be paid by SoftOx Solutions AS 0,01 NOK | +38,18% | 1,20 MNOK

2024-12-06 09:00:00 SoftOx Solution AS: Board recommendation to distribute the SoftOx Wound & Skin Care AS shares as dividend-in-kind and notice of Extraordinary General Meeting 0,01 NOK | +38,18% | 1,20 MNOK

2024-11-27 08:00:00 SoftOx Solution AS: Third Quarter Report 2024 0,01 NOK | -20,29% | 0,24 MNOK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

SoftOx Solutions

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden